Khiron Hails Brazilian Legalization of Cannabis

By: Tomas Ronolski - AllPennyStocks.com News

Wednesday, December 4, 2019

The legalization of cannabis in various countries around the world is being hailed as a godsend by those companies increasingly making their living at it.

Toronto-based Khiron Life Sciences Corp. (TSX-Venture:KHRN) gave particular attention to Wednesday’s announcement from the National Agency for Health Surveillance of Brazil, establishing a legalized environment for the sale and consumption of cannabis for medical use.

It’s of particular interest to Khiron because Brazil represents the largest addressable market in Latin America with a population of 208 million and a potential $229-Million U.S. patient network for medical cannabis.

Khiron will be taking part in in Brazil’s medical cannabis market through the Mercosur Regional Trading Bloc

Khiron co-founder Andres Galofre commented, "We congratulate legislators and the health authority in Brazil for their leadership in establishing a legalized environment for medical cannabis in the country.

"With a population of over 200 million, this will directly benefit the health and well-being of a significant number of patients in Brazil and affirms our position as a LatAm leader in a rapidly globalizing cannabis market."

Khiron shares moved into noon hour ahead nine cents, or 10.1%, to 98 cents, on volume of 288,000.

Copyright © 2019 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon